VAMIKIBART
UNII KP04MH1JTT

Substance Identification & Data

This profile provides standardized clinical and technical data for Vamikibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KP04MH1JTT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2744320-12-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KP04MH1JTT

CAS Registry Number

2744320-12-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VAMIKIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199126

National Cancer Institute reference terminology for clinical and research data.

INN ID

12560

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-114

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vamikibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VAMIKIBART

Common Names & Synonyms

IMMUNOGLOBULIN G2 (311-ALANINE), ANTI-(HUMAN INTERLEUKIN 6) (HUMAN MONOCLONAL RG6179 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL RG6179 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS IL6 (INTERLEUKIN 6)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY; GAMMA2 HEAVY CHAIN HUMANIZED (1-448) (VH ( HOMO SAPIENS IGHV1-69*11 (86.7%) -(IGHD) -IGHJ5*02 (90.9%) L123>T (117), CDR-IMGT (8.8.15) (26-33.51-58.97-111)) (1-122) - HOMO SAPIENS IGHG2*01, G2M.. CH2 V45.1, G2V8 CH2 A93 (CH1 (123-220), HINGE 1-12 (221-232), CH2 V45.1 (283), H93>A (311) (233-341), CH3 (342-446), CHS (447-448)) (123-448)), (136-218')-DISULFIDE WITH KAPPA LIGHT CHAIN CHIMERIC (1'-218') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV3- 2*01 (79.8%) -IGKJ2*03 (90.9%) S120>Q (104)/HOMO SAPIENS IGKV4-1*01 (79.2%) -IGKJ2*01 (100%), CDR-IMGT (10.3.9) (27-36.54-56.93-101)) (1'-111') -HOMO SAPIENS IGKC*01, KM3 A45.1 (157), V101 (195) (112'-218')); DIMER (224-224'':225-225'':228-228'':231-231'')-TETRAKISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1M, GLYCOFORM ALFA

RECOMBINANT HUMANISED IGG2 KAPPA ANTI-INTERLEUKIN 6 MONOCLONAL ANTIBODY RO7200220

VAMIKIBART [INN]

VAMIKIBART [USAN]

VAMIKIBART [WHO-DD]